GAMMA Investing’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$401K Buy
3,969
+106
+3% +$11K 0.01% 774
2026
Q1
$374K Sell
3,863
-83
-2% -$8.51K 0.02% 719
2025
Q4
$419K Sell
3,946
-21
-0.5% -$2.43K 0.02% 604
2025
Q3
$504K Buy
3,967
+214
+6% +$25.5K 0.03% 509
2025
Q2
$460K Buy
3,753
+1,387
+59% +$158K 0.03% 516
2025
Q1
$240K Buy
2,366
+419
+22% +$40.9K 0.02% 684
2024
Q4
$180K Buy
1,947
+352
+22% +$34.6K 0.02% 748
2024
Q3
$154K Buy
1,595
+411
+35% +$36.9K 0.02% 745
2024
Q2
$102K Buy
1,184
+568
+92% +$47.7K 0.01% 771
2024
Q1
$50.9K Buy
616
+149
+32% +$10.9K 0.01% 1037
2023
Q4
$33.2K Buy
+467
New +$30.2K 0.01% 1169

Other funds holding EHC

GAMMA Investing's EHC Position: Q2 2026 in Review

GAMMA Investing increased its Encompass Health (EHC) stake by 2.7% in Q2 2026, buying an estimated $11K and bringing the position to 3,969 shares worth $401K. The position accounts for 0.01% of the portfolio, ranked #774.

GAMMA Investing first reported a position in EHC in Q4 2023 and has held it in 11 quarters since. The position peaked at $504K in Q3 2025. 597 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • GAMMA Investing held 3,969 shares of Encompass Health worth $401K as of Q2 2026.
  • GAMMA Investing bought 106 Encompass Health shares in Q2 2026, an estimated $11K.
  • Encompass Health made up 0.01% of GAMMA Investing's portfolio in Q2 2026, its #774 holding.
  • GAMMA Investing first reported a position in Encompass Health in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's Encompass Health position peaked at $504K in Q3 2025.
  • 597 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.